Accessibility Menu
 
Translational Development Acquisition Corp. logo

Translational Development Acquisition Corp.

(NASDAQ) TDAC

Current Price$10.59
Market Cap$232.88M
Since IPO (2025)+6%
5 YearN/A
1 Year+4%
1 Month+0%

Translational Development Acquisition Corp. Financials at a Glance

Market Cap

$232.88M

Revenue (TTM)

$0.00

Net Income (TTM)

$6.36M

EPS (TTM)

$0.29

P/E Ratio

36.60

Dividend

$0.00

Beta (Volatility)

0.25 (Low)

Price

$10.59

Volume

0

Open

$10.59

Previous Close

$10.59

Daily Range

$10.59 - $10.59

52-Week Range

$10.15 - $10.69

TDAC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Translational Development Acquisition Corp.

Industry

Capital Markets

Employees

2

CEO

Michael B. Hoffman, MBA

Headquarters

New York City, NY 10006, US

TDAC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

4%

Return on Capital

-1%

Return on Assets

4%

Earnings Yield

2.73%

Dividend Yield

0.00%

Payout Ratio

2.02%

Stock Overview

Market Cap

$232.88M

Shares Outstanding

21.91M

Volume

0

Avg. Volume

5.49K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$944.54K

EBITDA

$944.54K

Operating Cash Flow

$608.39K

Capital Expenditure

$3.00

Free Cash Flow

$608.39K

Cash & ST Invst.

$29.79K

Total Debt

$200.00K

Translational Development Acquisition Corp. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$553.29K

N/A

Gross Profit

$23.22K

N/A

Gross Margin

4.20%

N/A

Market Cap

$232.88M

N/A

Market Cap/Employee

$116.44M

N/A

Employees

2

N/A

Net Income

$1.60M

+19939.5%

EBITDA

$162.34K

-20.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$170.21K

+100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$200.00K

-100.0%

Return on Assets

3.50%

N/A

Return on Invested Capital

-0.52%

N/A

Free Cash Flow

$7.99M

+1084.7%

Operating Cash Flow

$7.99M

+1084.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MACIMelar Acquisition Corp. I
$10.82+0.09%
SZZLSizzle Acquisition Corp. II
$10.30-0.10%
CEPOCantor Equity Partners I, Inc. Class A Ordinary Shares
$10.59-0.05%
FACTFACT II Acquisition Corp
$10.57+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AMZNAmazon
$265.06+0.01%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About TDAC

What is the current price of Translational Development Acquisition Corp.?

Translational Development Acquisition Corp. is trading at $10.59 per share.

What is the 52-week range for Translational Development Acquisition Corp.?

Over the past 52 weeks, Translational Development Acquisition Corp. has traded between $10.15 and $10.69.

How much debt does Translational Development Acquisition Corp. have?

As of the most recent reporting period, Translational Development Acquisition Corp. reported total debt of $200,000.

How much cash does Translational Development Acquisition Corp. have on hand?

Translational Development Acquisition Corp. reported $29,787 in cash and cash equivalents in its most recent financial results.

What is Translational Development Acquisition Corp.’s dividend yield?

Translational Development Acquisition Corp. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.